1 results match your criteria: "People's Republic of China. Electronic address: lixd@sj-hospital.org.[Affiliation]"
Serum amyloid A1 can be a novel biomarker for evaluating the presence and severity of acute coronary syndrome.
Clin Biochem
November 2020
Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang 110004, People's Republic of China. Electronic address:
Background: Serum amyloid A (SAA) is an acute phase protein and a novel inflammatory biomarker of cardiovascular diseases. Of the four subtypes, SAA1 is the most representative biomarker. In this study, we aimed to assess the value of SAA1 as a novel biomarker for evaluating the presence and severity of acute coronary syndrome (ACS) in Chinese patients.
View Article and Find Full Text PDF